Rhabdomyolysis in Patients Hospitalized With COVID-19 Infection: Five Case Series

The novel SARS-CoV-2 virus (severe acute respiratory syndrome coronavirus 2) is now known to cause acute respiratory distress, cytokine storm, and coagulopathy. Multiple other manifestations have been published in recent literature. Rhabdomyolysis is a syndrome of muscle damage, with release of intr...

Full description

Bibliographic Details
Main Authors: Shikha G. Khosla MD, Eric S. Nylen MD, Rahul Khosla MD
Format: Article
Language:English
Published: SAGE Publishing 2020-12-01
Series:Journal of Investigative Medicine High Impact Case Reports
Online Access:https://doi.org/10.1177/2324709620984603
_version_ 1818323249588600832
author Shikha G. Khosla MD
Eric S. Nylen MD
Rahul Khosla MD
author_facet Shikha G. Khosla MD
Eric S. Nylen MD
Rahul Khosla MD
author_sort Shikha G. Khosla MD
collection DOAJ
description The novel SARS-CoV-2 virus (severe acute respiratory syndrome coronavirus 2) is now known to cause acute respiratory distress, cytokine storm, and coagulopathy. Multiple other manifestations have been published in recent literature. Rhabdomyolysis is a syndrome of muscle damage, with release of intracellular contents into circulation. It is characterized by marked elevations of creatinine kinase levels and myoglobinuria. In this article, we describe a series of 5 cases who were admitted with COVID-19 pneumonia and had severe muscle injury, as demonstrated by significant elevation (>5 times upper limit of normal) of creatinine kinase levels likely secondary to SARS-CoV-2 virus. The median age for these patients was 65 years, and most of them suffered from diabetes and hyperlipidemia. All patients were hypertensive males. Four out of 5 patients had preserved kidney function at baseline and were chronic kidney disease (CKD) stage 2 or better. However, most of them suffered significant kidney injury and at the time of discharge one patient was CKD stage 2 or better, 2 were CKD stage 3 or worse, and 2 patients had renal failure and died due to complications of SARS-CoV-2 infection.
first_indexed 2024-12-13T11:09:42Z
format Article
id doaj.art-9618d8fc5e944a5798ef4e9edb5a89b3
institution Directory Open Access Journal
issn 2324-7096
language English
last_indexed 2024-12-13T11:09:42Z
publishDate 2020-12-01
publisher SAGE Publishing
record_format Article
series Journal of Investigative Medicine High Impact Case Reports
spelling doaj.art-9618d8fc5e944a5798ef4e9edb5a89b32022-12-21T23:48:48ZengSAGE PublishingJournal of Investigative Medicine High Impact Case Reports2324-70962020-12-01810.1177/2324709620984603Rhabdomyolysis in Patients Hospitalized With COVID-19 Infection: Five Case SeriesShikha G. Khosla MD0Eric S. Nylen MD1Rahul Khosla MD2George Washington University, Washington, DC, USAGeorge Washington University, Washington, DC, USAGeorge Washington University, Washington, DC, USAThe novel SARS-CoV-2 virus (severe acute respiratory syndrome coronavirus 2) is now known to cause acute respiratory distress, cytokine storm, and coagulopathy. Multiple other manifestations have been published in recent literature. Rhabdomyolysis is a syndrome of muscle damage, with release of intracellular contents into circulation. It is characterized by marked elevations of creatinine kinase levels and myoglobinuria. In this article, we describe a series of 5 cases who were admitted with COVID-19 pneumonia and had severe muscle injury, as demonstrated by significant elevation (>5 times upper limit of normal) of creatinine kinase levels likely secondary to SARS-CoV-2 virus. The median age for these patients was 65 years, and most of them suffered from diabetes and hyperlipidemia. All patients were hypertensive males. Four out of 5 patients had preserved kidney function at baseline and were chronic kidney disease (CKD) stage 2 or better. However, most of them suffered significant kidney injury and at the time of discharge one patient was CKD stage 2 or better, 2 were CKD stage 3 or worse, and 2 patients had renal failure and died due to complications of SARS-CoV-2 infection.https://doi.org/10.1177/2324709620984603
spellingShingle Shikha G. Khosla MD
Eric S. Nylen MD
Rahul Khosla MD
Rhabdomyolysis in Patients Hospitalized With COVID-19 Infection: Five Case Series
Journal of Investigative Medicine High Impact Case Reports
title Rhabdomyolysis in Patients Hospitalized With COVID-19 Infection: Five Case Series
title_full Rhabdomyolysis in Patients Hospitalized With COVID-19 Infection: Five Case Series
title_fullStr Rhabdomyolysis in Patients Hospitalized With COVID-19 Infection: Five Case Series
title_full_unstemmed Rhabdomyolysis in Patients Hospitalized With COVID-19 Infection: Five Case Series
title_short Rhabdomyolysis in Patients Hospitalized With COVID-19 Infection: Five Case Series
title_sort rhabdomyolysis in patients hospitalized with covid 19 infection five case series
url https://doi.org/10.1177/2324709620984603
work_keys_str_mv AT shikhagkhoslamd rhabdomyolysisinpatientshospitalizedwithcovid19infectionfivecaseseries
AT ericsnylenmd rhabdomyolysisinpatientshospitalizedwithcovid19infectionfivecaseseries
AT rahulkhoslamd rhabdomyolysisinpatientshospitalizedwithcovid19infectionfivecaseseries